News & Insights

On October 13, 2025, California Governor Newsom signed Senate Bill 243 on Companion Chatbots (“SB 243”) into law, being the first U.S. state law that requires operators of “companion chatbot” platforms to meet design, disclosure, safety and reporting requirements, including obligations to restrict harmful content and provide disclosures intended to address online safety

California Governor Gavin Newsom signed three powerful privacy laws further expanding privacy protections for consumers and compliance obligations for businesses handling personal information in the state

The SEC's new electronic filing system, EDGAR Next, is live and, as of September 15, 2025, became the mandatory filing system for all SEC filers—including  for private funds and their managers

Gunderson Dettmer co-sponsored the Longwood Healthcare Leaders Boston CEO Summit 2025, a two-day, invitation-only conference that convenes approximately 250 biopharma CEOs, R&D executives, government officials, life science investors, and leading academics for off-the-record discussions

Join us for an Exclusive Premiere on What’s Next in Biotech with Gunderson Partner and Chair of Life Sciences Tim Ehrlich and Venrock Managing Partner Bryan Roberts

Gunderson is sponsoring Venture Atlanta, a 2 day conference connecting the Southeast’s most promising tech companies with investors from across the country

Gunderson Dettmer represented long-time client BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company on a mission to make powerful and accessible genetic tests available to all, in its initial public offering of 4.6 million shares of Class A common stock at a price to the public of $60 per share, generating approximately $273.1 billion in aggregate gross proceeds.

Aeva Technologies, a leader in next-generation sensing and perception systems, announces Apollo’s purchase of $100 million in aggregate principal amount of 4.375% convertible senior notes due 2032.

Leerink Partners and Goldman Sachs & Co. LLC served as representatives of the underwriters in the common stock offering of Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on creating best-in-class therapies.

Gunderson Dettmer was recognized as a 2025 Inc. Power Partner Award Winner in the category of business and product services.

Gunderson Dettmer has been named the 2025 winner of the American Legal Technology Award (ALTA) in the Law Firm category, recognizing the firm’s leadership in applying advanced technology to redefine how legal services are delivered to clients in the global innovation economy

Gunderson Dettmer and Alpha Edison last night announced RxPost as the winner of PitchLive.LA which took place on October 14 during LA Tech Week